Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2016  |  Volume : 12  |  Issue : 45  |  Page : 21-24

Comparative pharmacokinetics of ginsenoside Rg3 and ginsenoside Rh2 after oral administration of ginsenoside Rg3 in normal and walker 256 tumor-bearing rats


1 Department of Chinese Medicine Analysis, Liaoning University of Traditional Chinese Medicine, 77 Life One Road, DD Port, Dalian 116600, China
2 Institute of Traditional Chinese Medicine, Liaoning Institute for Drug Control, 7 Congshan West Road, Shenyang 110036, China
3 Dalian Fusheng Natural Drug Development Co., Ltd, 5 Tiexi Middle Road, Development District, Dalian 116600, China

Correspondence Address:
Fu Li
Dalian Fusheng Natural Drug Development Co., Ltd., 5 Tiexi Middle Road, Development District, Dalian 116600
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1296.176014

Rights and Permissions

Background: Ginseng is Chinese traditional herbal medicine, and the ginsenoside Rg 3 is the main bioactive ingredient for the anti-tumor effect. However, there is no study on pharmacokinetics (PKs) of ginsenoside Rg 3 and its main metabolite after oral ginsenoside Rg 3 in tumor-bearing plasma. The aim of this study was to investigate the PK profiles of ginsenoside Rg 3 and ginsenoside Rh 2 after oral administration of pure ginsenoside Rg 3 were administered, and compare the difference of the PK profiles between normal and Walker 256 tumor-bearing rats. Materials and Methods: The concentrations of two ginsenosides in plasma were determined by using a simple and rapid high-performance liquid chromatography. All the rats were divided randomly into two groups (Walker 256 tumor-bearing and normal groups). Each group received oral administration of 50 mg/kg ginsenoside Rg 3 . Results: The results showed that ginsenoside Rh 2, possibly as a glycosylation hydrolysis product of ginsenoside Rg 3, were found in plasma after oral administration of ginsenoside Rg 3 to rats. Ginsenoside Rg 3 had shown better absorption than ginsenoside Rh 2, whether the oral administration of ginsenoside Rg 3 , normal rats showed better absorption than tumor-bearing rats. Discussion and Conclusion: The PKs properties of the ginsenoside Rg 3 and ginsenoside Rh 2 differed between tumor-bearing rats and normal rats, including area under the plasma level/time curve and concentration maximum (P < 0.05).


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1658    
    Printed26    
    Emailed0    
    PDF Downloaded19    
    Comments [Add]    
    Cited by others 4    

Recommend this journal